Basics Aura Biosciences, Inc. Common Stock IPO Date: October 29, 2021 Sector: Healthcare Industry: Biotech Market Cap: $406.75M Activated in VL: True Average Daily Range Avg Daily Range: $0.37 | 3.10% Avg Daily Range (30 D): $0.19 | 2.96% Avg Daily Range (90 D): $0.21 | 3.59% Institutional Daily Volume Avg Daily Volume: .1M Avg Daily Volume (30 D): .13M Avg Daily Volume (90 D): .19M Trade Size Avg Trade Size (Sh.): 71 Avg Trade Size (Sh.) (30 D): 66 Avg Trade Size (Sh.) (90 D): 74 Institutional Trades Total Inst.Trades: 84 Avg Inst. Trade: $2.16M Avg Inst. Trade (30 D): $1.51M Avg Inst. Trade (90 D): $1.91M Avg Inst. Trade Volume: .23M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.66M Avg Closing Trade (30 D): $2.37M Avg Closing Trade (90 D): $1.64M Avg Closing Volume: 375.63K     News May 15, 2025 @ 1:32 PM Aura Biosciences Announces Pricing of Public Offer... Source: Globe Newswire Apr 2, 2025 @ 11:00 AM Aura Biosciences Announces Appointment of Teresa B... Source: N/A Mar 3, 2025 @ 12:00 PM Aura Biosciences Announces Additional Data from On... Source: N/A Oct 15, 2024 @ 4:40 PM 3 Small-Cap Stocks Ready to Deliver Significant Gr... Source: Marketbeat, Benzinga Contributor Jul 1, 2024 @ 1:17 PM UnitedHealth (UNH), Amedisys Clear Merger Hurdle W... Source: Zacks Equity Research Financials   TTM Q4 2024 FY 2024 Basic EPS $-.55 $-.52 $-1.75 Diluted EPS $-.55 $-.52 $-1.75 Revenue $ $ $ Gross Profit $ $ $ Net Income / Loss $ -27.48M $ -25.83M $ -86.92M Operating Income / Loss $ -29.04M $ -27.81M $ -96.12M Cost of Revenue $ $ $ Net Cash Flow $ 6.55M $ 6.29M $ -9.39M PE Ratio